Suboxone vs. Methadone for Opioid Use Disorder – Broadway Treatment Center

Medically reviewed by the Broadway Treatment Center Editorial Team. Last updated June 29, 2026. This article is for education only and is not medical advice. Broadway Treatment Center is a placement and referral service, not a treatment facility; we connect people with licensed providers in our Orange County and California network and verify benefits before any commitment.

Suboxone vs. Methadone: How the Two Main Opioid Use Disorder Medications Compare

Suboxone and methadone are the two most widely used medications for treating opioid use disorder, and they work in different ways. Methadone is a full opioid agonist dispensed only through federally certified opioid treatment programs (often called methadone clinics), while Suboxone is a combination of buprenorphine (a partial opioid agonist) and naloxone that any clinician with a standard DEA registration can now prescribe in an office or by telehealth. Both are first-line, evidence-based treatments endorsed by federal health agencies; the right choice depends on the severity of the opioid use disorder, how a person is using opioids, access, and personal preference. Broadway Treatment Center is a placement and referral service, not a treatment facility. We help you understand these options and connect you with licensed providers across Orange County and California who prescribe and manage these medications.

Medication-Assisted Treatment in Orange County

Not Sure Whether Suboxone or Methadone Is Right for You or a Loved One?

Broadway Treatment Center helps you weigh the medication options for opioid use disorder and connects you with licensed providers in our network who can complete a full assessment. Our care navigators are available 24/7.

Call Now: (714) 400-2048

If you or someone near you is experiencing a medical emergency or a suspected opioid overdose, call 911 immediately. Signs of overdose include slow or stopped breathing, blue or gray lips or fingertips, pinpoint pupils, and unresponsiveness; if naloxone (Narcan) is available, give it and stay until help arrives. For a mental health or suicidal crisis, call or text 988 to reach the Suicide and Crisis Lifeline. For confidential help finding opioid use disorder treatment in Orange County, call Broadway Treatment Center at (714) 400-2048.

Quick Answer: The Core Difference Between Suboxone and Methadone

Both medications reduce opioid cravings and withdrawal by acting on the same brain receptors that opioids like heroin, fentanyl, and prescription painkillers target, but they do it with different intensity and through very different systems of care. Methadone fully activates the opioid receptor and is delivered in a structured clinic setting with daily or take-home dosing. Buprenorphine, the active ingredient in Suboxone, only partially activates the receptor and has a built-in safety ceiling, which is part of why it can be prescribed in regular medical offices and increasingly through telehealth.

  • Methadone: full opioid agonist, Schedule II, dispensed only at certified opioid treatment programs (OTPs), strong option for severe or long-standing opioid use disorder and for high-tolerance fentanyl use.
  • Suboxone (buprenorphine + naloxone): partial opioid agonist with a ceiling effect, Schedule III, prescribed in offices and by telehealth, lower overdose risk on its own, naloxone component discourages misuse by injection.
  • Both are FDA-approved, considered first-line “medications for opioid use disorder” (MOUD), and work best when combined with counseling and ongoing support, not as standalone fixes.

What Are Suboxone and Methadone?

Methadone

Methadone is a long-acting, full opioid agonist that has been used to treat opioid use disorder for more than 50 years. Because it fully activates the mu-opioid receptor, a correct, individualized dose can hold withdrawal and cravings steady for 24 hours or longer without producing the highs and lows of short-acting opioids. Methadone is a Schedule II controlled substance, and when used for opioid use disorder in the United States it can only be dispensed through a Substance Abuse and Mental Health Services Administration (SAMHSA) certified opioid treatment program, commonly known as a methadone clinic. Many people start with daily visits to take their dose under observation and can earn take-home doses over time as they stabilize.

Suboxone (Buprenorphine and Naloxone)

Suboxone is a brand-name combination of two medicines: buprenorphine and naloxone. Buprenorphine is a partial opioid agonist, meaning it activates the same receptor as methadone but only to a limited degree, with a “ceiling effect” that caps its opioid activity even as the dose rises. That ceiling is the reason buprenorphine carries a lower risk of dangerous respiratory depression than full agonists when taken as directed. The second ingredient, naloxone, is an opioid blocker that is poorly absorbed when the film or tablet is taken under the tongue as intended, but can trigger withdrawal if the product is dissolved and injected, which is why it is included as an abuse-deterrent. Buprenorphine products are Schedule III, a lower-restriction category than methadone, and they are available as Suboxone, generic buprenorphine/naloxone, mono-product buprenorphine (Subutex and generics), and long-acting injectable forms such as Sublocade. To learn more about how this medication works, see our guide on how Suboxone works.

How Each Medication Works in the Brain

Understanding the pharmacology helps explain why these medications behave so differently in real life. Opioids like heroin, fentanyl, oxycodone, and hydrocodone produce their effects by binding to and fully activating mu-opioid receptors. Over time, repeated use changes the brain so that the receptors expect that stimulation, and stopping abruptly produces the intense withdrawal that drives the cycle of use. Medications for opioid use disorder work by occupying those same receptors in a more controlled, sustained way.

  • Methadone (full agonist): activates the receptor completely, like the opioids it replaces, but its long half-life and steady blood levels prevent the rapid spikes that produce euphoria and the crashes that produce withdrawal. There is no pharmacological ceiling, so the dose must be raised carefully under medical supervision.
  • Buprenorphine (partial agonist): binds very tightly to the receptor but only partially activates it. Its tight binding can actually displace other opioids already on the receptor, which is useful for blocking the effect of additional opioid use but also the reason it can cause precipitated withdrawal if started too soon. Its ceiling effect means that beyond a certain dose, taking more does not meaningfully increase opioid effects or respiratory suppression.
  • Naltrexone (for context): a third option, naltrexone, is a full opioid antagonist that blocks the receptor entirely. It is not an opioid and carries no overdose or dependence risk, but a person must be fully detoxed before starting it, which makes it a different kind of choice than the two agonist medicines compared here.

These medications are not “trading one addiction for another,” a myth that keeps many people from lifesaving care. Used as prescribed, they stabilize brain chemistry, eliminate the highs and lows, and free a person to work, parent, and rebuild their life. The National Institute on Drug Abuse and SAMHSA both describe methadone and buprenorphine as effective, evidence-based treatments. For broader context on this approach, see Broadway’s overview of medication-assisted treatment.

Suboxone vs. Methadone at a Glance

FeatureSuboxone (buprenorphine/naloxone)Methadone
Drug classPartial opioid agonist + opioid antagonistFull opioid agonist
DEA scheduleSchedule IIISchedule II
Where it is dispensedDoctor’s office, clinic, telehealth, retail pharmacyCertified opioid treatment program (OTP) only
Typical early visitsOffice or virtual follow-up; prescription filled at a pharmacyDaily, often observed, dosing at the clinic at first
Overdose risk on its ownLower, due to ceiling effectHigher, no ceiling; requires careful dose titration
Misuse deterrentNaloxone component discourages injectionStructured clinic dispensing and observation
Common formsSublingual film/tablet, monthly injectable (Sublocade)Oral liquid, tablet, dispersible tablet
Often considered forMild to moderate or stable opioid use disorder; people wanting office-based careSevere, long-standing use; high fentanyl tolerance; when buprenorphine has not held
Stopping the medicationGradual taper, milder withdrawal profileGradual taper, can be more prolonged
General comparison for education only. The safest medication and dose are determined by a licensed clinician through individual assessment.

Where and How You Get Each Medication

One of the biggest practical differences between these two medications is the system you have to navigate to get them, and recent federal changes have widened access to buprenorphine in particular.

Methadone: the opioid treatment program model

Methadone for opioid use disorder is dispensed only at SAMHSA-certified opioid treatment programs. In practice this usually means going to the clinic in person, especially early in treatment, to take an observed dose. This structure provides daily contact, built-in monitoring, and wraparound counseling, which some people find stabilizing, but it can also be a barrier for those who live far from a clinic, work inflexible hours, or lack transportation. Over time, as a person demonstrates stability, federal rules allow them to earn take-home doses so they do not have to visit daily.

In 2024, SAMHSA updated the federal regulations governing opioid treatment programs (42 CFR Part 8) for the first time in two decades. According to SAMHSA, the final rule took effect April 2, 2024, with a compliance date of October 2, 2024, and it gave programs more flexibility to offer take-home methadone doses based on overdose-prevention principles and shared decision-making rather than rigid time-in-treatment criteria. The rule also expanded the use of telehealth for screening and removed the long-standing requirement that a person have a one-year history of opioid addiction before admission.

Buprenorphine/Suboxone: office-based and telehealth access

Buprenorphine can be prescribed in ordinary medical settings, and access expanded substantially after a major 2023 law change. Section 1262 of the Consolidated Appropriations Act, 2023, signed into law on December 29, 2022, eliminated the federal “X-waiver” (the DATA-waiver) that previously limited which clinicians could prescribe buprenorphine and how many patients they could treat. As confirmed by SAMHSA and the DEA Diversion Control Division, any clinician who holds a current DEA registration with Schedule III authority may now prescribe buprenorphine for opioid use disorder, subject to applicable state law, without a special waiver, patient caps, or counseling-certification requirements. Separately, since June 27, 2023, practitioners applying for or renewing a DEA registration must attest to completing at least eight hours of training on substance use disorders under the MATE Act.

The result is that buprenorphine can often be started and managed through a primary care doctor, an addiction medicine clinic, or a telehealth visit, with prescriptions filled at a regular pharmacy. That flexibility makes it a practical option for many people who cannot structure their lives around daily clinic visits. Broadway’s care navigators can help you understand which model fits your situation and connect you with providers in our Orange County and California network who offer both pathways.

The Right Medication Depends on Your History, Tolerance, and Goals

Severity of use, fentanyl tolerance, other health conditions, pregnancy, and how much structure you need all shape whether buprenorphine or methadone is the safer fit. A clinical assessment can help determine the safest next step, and we verify your benefits before any commitment.

How Effective Are They? What the Evidence Shows

Decades of research support both methadone and buprenorphine as effective treatments for opioid use disorder. Federal health agencies, including the National Institute on Drug Abuse and SAMHSA, describe medications for opioid use disorder as the standard of care, noting that they can keep people in treatment longer, reduce illicit opioid use, lower the risk of overdose death, and decrease the spread of infectious disease compared with no medication. Treatment with these medications is associated with substantial reductions in opioid-related mortality.

It is important to frame this honestly. No medication cures opioid use disorder, and outcomes vary from person to person depending on dose, length of treatment, co-occurring conditions, and the support around them. The medications are most effective when they are dosed adequately, continued long enough (often months to years, not days), and paired with counseling and recovery support. Stopping early, before the brain has had time to stabilize, is one of the most common reasons people return to use. The choice between methadone and buprenorphine is less about which is “stronger” and more about which a person can stay on safely and consistently.

Safety, Side Effects, and Overdose Risk

Both medications are generally safe when prescribed and monitored appropriately, but their risk profiles differ.

Methadone safety considerations

Because methadone is a full agonist with no ceiling effect, the dose must be raised slowly and carefully, particularly during the first two weeks when the risk of dangerous sedation and respiratory depression is highest. Methadone can also affect heart rhythm (QT prolongation) at higher doses, so clinicians may monitor this. The structured clinic model exists in part to manage these risks. Combining methadone with benzodiazepines, alcohol, or other sedatives sharply increases overdose risk and should only happen under medical guidance.

Suboxone safety considerations

Buprenorphine’s ceiling effect gives it a wider safety margin on its own, which is one reason it can be prescribed outside a clinic. It is not risk-free: combining it with benzodiazepines, alcohol, or other central nervous system depressants can still cause serious harm, and the medication can be misused. Common side effects of both medications can include constipation, sweating, sleep changes, and low libido. Anyone taking either medication should keep naloxone (Narcan) on hand and make sure family members know how to use it.

Never start, stop, switch, or change the dose of methadone or buprenorphine on your own. Sudden changes can trigger severe withdrawal or dangerously increase overdose risk. Always work with a licensed prescriber. If you witness an overdose, call 911 and give naloxone if available.

Starting Treatment: Induction and Precipitated Withdrawal

How a person starts each medication is one of the most clinically important differences, especially in the era of fentanyl.

With buprenorphine, a person usually has to be in mild to moderate opioid withdrawal before the first dose. Because buprenorphine binds so tightly to the receptor, taking it while other opioids are still active can knock those opioids off and cause sudden, intense “precipitated withdrawal.” Clinicians often use the Clinical Opiate Withdrawal Scale (COWS) to judge when it is safe to begin. Fentanyl complicates this because it lingers in body tissues longer than heroin, so timing the first buprenorphine dose can be trickier; some clinicians use low-dose or alternative induction strategies for people coming off fentanyl. Methadone does not carry the same precipitated-withdrawal risk because it is a full agonist, so it can sometimes be started earlier in the withdrawal process.

This is also where supervised medical detox and stabilization matter. Many people benefit from beginning medication under clinical supervision rather than at home. To understand what opioid withdrawal looks like, see Broadway’s guides to the heroin withdrawal timeline and fentanyl withdrawal symptoms, and the overview of medical detox in Orange County.

Who Might Be a Better Fit for Each Medication?

There is no universal “better” medication. The most appropriate choice is individualized, and many people do well on either. That said, clinicians often weigh patterns like these:

  • Buprenorphine/Suboxone may suit people with milder or more stable opioid use disorder, those who want office-based or telehealth care, those who cannot get to a daily clinic, and those who prioritize a lower overdose-risk profile.
  • Methadone may suit people with severe, long-standing opioid use disorder, very high opioid tolerance (including heavy fentanyl use), those who have not stabilized on buprenorphine, and those who benefit from the structure and daily contact of a clinic.
  • Either can be appropriate for people who have relapsed on the other medication; switching between them is common and is done under medical supervision.

Other factors that influence the decision include co-occurring mental health conditions, other medications a person takes, liver or heart health, pregnancy, prior treatment experiences, and personal preference. Because opioid use disorder so often occurs alongside depression, anxiety, PTSD, or other conditions, integrated care matters; learn more about co-occurring disorders and addiction and dual diagnosis treatment.

Pregnancy and Opioid Use Disorder

For pregnant people with opioid use disorder, both methadone and buprenorphine are recommended over attempting to stop opioids abruptly, because untreated withdrawal can be dangerous for the pregnancy. Federal guidance and major medical organizations support medication treatment during pregnancy, with the specific choice and dose individualized by an obstetric and addiction care team. Babies exposed to these medications may experience neonatal opioid withdrawal, which is anticipated, monitored, and managed by the medical team after birth. Anyone who is pregnant or planning pregnancy should discuss the safest plan with a qualified clinician rather than stopping medication on their own.

Detox vs. Maintenance: A Common Misunderstanding

People often assume the goal of these medications is a fast taper to being “off everything.” In reality, the strongest evidence supports ongoing maintenance treatment, sometimes for years, because opioid use disorder is a chronic, relapsing condition. Using methadone or buprenorphine only for a short detox and then stopping is associated with high relapse rates and, dangerously, a higher overdose risk because tolerance drops quickly after stopping. The length of treatment is a medical decision made between a person and their prescriber, not a fixed timeline. The aim is stability and quality of life, not an arbitrary finish line.

How Broadway Treatment Center Helps

Broadway Treatment Center is a placement and referral service, not a treatment facility or a prescriber. We do not provide medication ourselves. What we do is help you cut through a confusing system: we listen to your situation, explain the options in plain language, verify your insurance benefits before any commitment, and connect you with licensed providers in our Orange County and California network who offer methadone, buprenorphine, naltrexone, and the surrounding counseling and recovery support. Here is how to take the next step:

  1. Call (714) 400-2048 to speak confidentially with a care navigator, available 24/7.
  2. Share the basics of the situation, what opioids are involved, how long, any health concerns, and what kind of care you are looking for.
  3. Let us verify benefits so you understand coverage before any commitment. You can also start with our insurance verification page.
  4. Get connected to licensed providers in our network for a full clinical assessment, which determines the safest medication and level of care.
  5. Begin treatment and follow-up with a plan that can include medication, counseling, and aftercare. Reach us anytime through our contact page.

Medication Is One Part of Opioid Recovery, Not the Whole Plan

The strongest outcomes pair medication with counseling, dual-diagnosis care, and aftercare. See how medication-assisted treatment fits into a complete recovery plan, and let us connect you with the right providers.

Explore Medication-Assisted Treatment

Frequently Asked Questions: Suboxone vs. Methadone

Is Suboxone or methadone better for opioid use disorder?

Neither is universally better; both are first-line, evidence-based treatments. Methadone is often considered for severe, long-standing use or very high opioid tolerance, while buprenorphine (Suboxone) is frequently chosen for its office-based access and lower overdose risk. The right fit is determined by a licensed clinician based on your history, health, and goals.

What is the main difference between Suboxone and methadone?

Methadone is a full opioid agonist dispensed only at certified opioid treatment programs, while Suboxone contains buprenorphine, a partial agonist with a safety ceiling, plus naloxone, and can be prescribed in offices and by telehealth. Methadone activates the opioid receptor fully; buprenorphine only partially.

Why does methadone require a clinic but Suboxone does not?

Federal law allows methadone for opioid use disorder to be dispensed only through SAMHSA-certified opioid treatment programs, which provide observed dosing and monitoring. Buprenorphine is a Schedule III medication that, since the 2023 elimination of the X-waiver, can be prescribed by any clinician with appropriate DEA registration, often in a regular office or by telehealth.

Which has a lower overdose risk?

On its own, buprenorphine generally carries a lower overdose risk than methadone because of its ceiling effect, which limits respiratory depression. Both medications become far more dangerous when combined with benzodiazepines, alcohol, or other sedatives. Keeping naloxone on hand is recommended for anyone in opioid treatment.

Can you switch from methadone to Suboxone or vice versa?

Yes, switching is common and done under medical supervision. Moving from methadone to buprenorphine requires careful timing to avoid precipitated withdrawal, since buprenorphine can displace methadone from the receptor. Never attempt to switch on your own; work with a prescriber.

What is precipitated withdrawal?

Precipitated withdrawal is sudden, intense withdrawal that can happen if buprenorphine is taken while other opioids are still active on the receptor. To avoid it, clinicians usually wait until a person is in mild to moderate withdrawal, often guided by the Clinical Opiate Withdrawal Scale (COWS), before the first dose.

Does fentanyl change how these medications are started?

It can. Fentanyl tends to linger in the body longer than heroin, which can make the timing of a first buprenorphine dose trickier and raise the chance of precipitated withdrawal. Some clinicians use low-dose or alternative induction approaches for people coming off fentanyl. This is a key reason to start medication under clinical guidance.

Are these medications just trading one addiction for another?

No. This is a common myth. Taken as prescribed, methadone and buprenorphine stabilize brain chemistry without producing a high, allowing people to function normally. Major federal health agencies consider them effective, evidence-based treatments, not a substitution of one addiction for another.

How long do you stay on Suboxone or methadone?

There is no fixed timeline. Because opioid use disorder is chronic, many people benefit from maintenance treatment for months or years. The duration is a medical decision made with a prescriber. Stopping too soon is linked to relapse and increased overdose risk because tolerance drops quickly.

What is the naloxone in Suboxone for?

The naloxone in Suboxone is an abuse-deterrent. It is poorly absorbed when the film or tablet is taken under the tongue as directed, so it does not interfere with treatment, but it can trigger withdrawal if someone tries to dissolve and inject the product. This discourages misuse.

Can I get Suboxone through telehealth?

In many cases, yes. Federal rules now allow buprenorphine to be prescribed in office-based and telehealth settings, subject to state law and the prescriber’s policies. Methadone, by contrast, still requires in-person dosing at a certified opioid treatment program, though telehealth can be used for some screening steps.

Do I need to be in withdrawal before my first dose?

For buprenorphine, usually yes, a person typically needs to be in mild to moderate withdrawal to avoid precipitated withdrawal. Methadone does not have the same requirement because it is a full agonist. Your prescriber will guide the exact timing.

Is medication enough, or do I also need counseling?

Medication works best as part of a broader plan. While medication alone reduces harm, combining it with counseling, peer support, and treatment for any co-occurring mental health conditions improves the odds of lasting recovery. Broadway can connect you with providers who offer that full continuum.

Are methadone and buprenorphine safe during pregnancy?

Both are recommended over abrupt opioid cessation during pregnancy because untreated withdrawal can be dangerous. The specific medication and dose are individualized by an obstetric and addiction care team. Anyone pregnant or planning pregnancy should discuss the safest plan with a qualified clinician and not stop medication on their own.

What is naltrexone, and how is it different?

Naltrexone is a third medication for opioid use disorder, but it is an opioid blocker (antagonist), not an agonist. It carries no dependence or overdose risk, but a person must be fully detoxed before starting it, which makes it a different kind of choice than methadone or buprenorphine. A clinician can help determine if it fits your situation.

Does insurance cover Suboxone or methadone treatment?

Many health plans cover medications for opioid use disorder and the associated care, but coverage varies by plan and provider. We verify your benefits before any commitment so you understand your options. Start with our insurance verification page or call (714) 400-2048.

How do I get help today in Orange County?

Call Broadway Treatment Center at (714) 400-2048 to speak with a care navigator, available 24/7. We will explain your options, verify benefits, and connect you with licensed providers in our Orange County and California network. In an emergency, call 911; for a mental health crisis, call or text 988.

A Final Word

The most important decision is not Suboxone versus methadone; it is starting an evidence-based treatment at all. Both medications save lives, and the “right” one is the one a person can access, tolerate, and stay on with the support they need. If you are weighing these options for yourself or someone you love, you do not have to figure it out alone. Broadway Treatment Center can help you understand the choices and connect you with licensed providers who will complete a proper assessment and build a plan around your situation.

You can reach Broadway Treatment Center confidentially at (714) 400-2048, 24/7. If you or someone near you is in immediate danger or may be overdosing, call 911 now and give naloxone if it is available. For a mental health or suicidal crisis, call or text 988 to reach the Suicide and Crisis Lifeline.

Trusted Sources and Authority References

Editorial Disclaimer

This article was produced and reviewed by the Broadway Treatment Center Editorial Team for general education and is not a substitute for professional medical advice, diagnosis, or treatment. It does not recommend a specific medication for any individual. Broadway Treatment Center is a placement and referral service, not a treatment facility, a prescriber, or a pharmacy; we connect people with licensed, independent providers in our Orange County and California network and verify insurance benefits before any commitment. We do not provide treatment directly. Admission to any program depends on clinical assessment, availability, and insurance authorization, and no specific medication, coverage, or outcome is guaranteed in advance. Always consult a qualified clinician before starting, stopping, or changing any medication. If you are experiencing a medical emergency or suspected overdose, call 911. For a mental health or suicidal crisis, call or text 988.